The Centers for Disease Control and Prevention (CDC) will hold a meeting on Wednesday to review guidelines for the use of Pfizer and BioNTech’s COVID-19 vaccine in children aged 12 to 15.
The Advisory Committee on Immunization Practices (ACIP) makes recommendations to the Centers for Disease Control and Prevention (CDC) that several countries will consider when administering the two-shot vaccine to adolescents this week.
The US Food and Drug Administration approved a vaccine for children under the age of six on Monday, providing relief to parents anxious to get their children back to school and summer camps.
According to CDC results, roughly one-third of all Americans were completely vaccinated. However, in recent weeks, the rate of vaccination has slowed.
Including a vaccine for adolescents can help reduce the spread of the virus as more infectious strains circulate, potentially shortening Americans’ recovery time.
“I think we should be professionally educated, full-time school in the fall,” CDC Director Rochelle Walensky said on Tuesday at a CNBC health summit.
Children are thought to have a lower risk of serious COVID-19 infection, but they can still transmit the virus.
Pfizer is conducting a special vaccine test for children as young as six months old, with findings expected in September for the use of vaccine for children aged two to eleven. The age group 12-15 years old was measured as part of Pfizer’s expansion of the 46,000-person survey.
The Committee will hear from Pfizer and several CDC officials about the vaccine’s protection and effectiveness in children.
CDC | Don’t forget to follow us on Twitter @njtimesofficial. To get latest updates